Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
The serum levels of Ceruloplasmin (CER), Properdin Factor B (PFB) and Copper (CU) were evaluated in a series of 40 patients with Hodgkin's Disease and 46 patients with non-Hodgkin's lymphoma. Concentrations of CER and PFB were determined by rate nephelometry and CU concentrations by the bathocuproine colorimetric method. The results obtained demonstrated that CER, together with the well documented CU, can be used for monitoring Hodgkin's Disease.
Casamassima
A
A
Immunology Laboratory, Oncology Institute, Bari, Italy.
Addabbo
L
L
Caporusso
L
L
Lorusso
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D002570:Ceruloplasmin / Q000378:metabolism*; D011415:Complement Factor B / Q000097:blood*; D003300:Copper / Q000097:blood*; D005260:Female; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D008223:Lymphoma / Q000097:blood*; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D008297:Male; D008875:Middle Aged
D014408:Biomarkers, Tumor; D003300:Copper; D002570:Ceruloplasmin; D011415:Complement Factor B